Report of Proposed Sale of Securities (144)
May 08 2015 - 1:58PM
Edgar (US Regulatory)
|
OMB
APPROVAL
OMB Number: 3235-0101
Expires: May 31, 2017
Estimated average burden hours
per response ............. 1.00
SEC USE ONLY
DOCUMENT SEQUENCE NO.
CUSIP NUMBER
WORK LOCATION |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
FORM
144
NOTICE OF PROPOSED SALE OF SECURITIES
PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
ATTENTION: Transmit
for filing 3 copies of this form concurrently with either placing an order with a broker to execute sale
or executing a sale directly with a market maker. |
1 (a) NAME OF ISSUER (Please type or print)
Esperion Therapeutics, Inc. |
(b) IRS IDENT. NO.
26-1870780 |
(c) S.E.C. FILE NO.
001-35986 |
1 (d) ADDRESS OF ISSUER
3891 Ranchero Drive, Suite 150 |
STREET
|
CITY
Ann Arbor |
STATE
Michigan |
ZIP CODE
48108 |
(e) TELEPHONE NO. |
AREA CODE
(734) |
NUMBER
887-3903 |
2 (a) NAME OF PERSON FOR
WHOSE ACCOUNT THE SECURITIES ARE TO BE SOLD
Blackboard Ventures Inc. |
|
(b) RELATIONSHIP TO ISSUER
Dist. from affiliate |
(c) ADDRESS STREET
5650 Yonge Street Suite 300 |
CITY
Toronto |
STATE
ON |
ZIP CODE
M2M 4H5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INSTRUCTION: The
person filing this notice should contact the issuer to obtain the I.R.S. Identification Number and the S.E.C. File Number.
3 (a)
Title
of the Class of
Securities To
Be Sold |
(b)
Name
and Address of Each Broker Through Whom the
Securities are to be Offered or Each Market Maker
who is Acquiring the Securities |
SEC USE ONLY |
(c)
Number
of Shares
or Other Units
To Be Sold
(See instr. 3(c)) |
(d)
Aggregate
Market
Value
(See instr. 3(d)) |
(e)
Number
of Shares
or Other Units
Outstanding
(See instr. 3(e)) |
(f)
Approximate
Date of Sale
(See
instr. 3(f))
(MO. DAY YR.) |
(g)
Name of
Each
Securities
Exchange
(See instr. 3(g)) |
Broker-Dealer
File Number |
Common Stock |
Credit Suisse Securities, 11 Madison Avenue,
New York, NY 10010 USA |
|
3,636 |
$365,418 |
20,437,313 |
ASAP |
NASDAQ |
INSTRUCTIONS:
1. (a) Name of issuer
(b) Issuer’s I.R.S. Identification
Number
(c) Issuer’s S.E.C. file
number, if any
(d) Issuer’s address,
including zip code
(e) Issuer’s telephone
number, including area code
2. (a) Name of person for whose
account the securities are to be sold
(b) Such person’s relationship
to the issuer (e.g., officer, director, 10% stockholder, or member of immediate family of any of the foregoing)
(c) Such person’s address,
including zip code |
3. (a) Title of the class of
securities to be sold
(b) Name and address of each
broker through whom the securities are intended to be sold
(c) Number of shares or other
units to be sold (if debt securities, give the aggregate face amount)
(d) Aggregate market value of
the securities to be sold as of a specified date within 10 days prior to the filing of this notice
(e) Number of shares or other
units of the class outstanding, or if debt securities the face amount thereof outstanding, as shown by the most recent report or
statement published by the issuer
(f) Approximate date on which
the securities are to be sold
(g) Name of each securities exchange,
if any, on which the securities are intended to be sold |
Potential persons who are to respond to the collection
of information contained in this form are not
required to respond unless the form displays a currently valid OMB control number. SEC
1147 (08-07)
TABLE I –– SECURITIES TO BE SOLD
Furnish
the following information with respect to the acquisition of the securities to be sold
and with respect to the payment of all or any part of the purchase price or other consideration
therefor:
Title of
the Class |
Date you
Acquired |
Nature of Acquisition Transaction |
Name of Person from Whom Acquired
(If gift, also give date donor acquired) |
Amount of
Securities Acquired |
Date of
Payment |
Nature of Payment |
Common Stock |
4/28/2015
|
Distribution from Limited Partnership |
Aisling Capital II, L.P. |
3,636 |
6/26/2013
|
Cash
|
| INSTRUCTIONS: | If the securities were purchased and full
payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the
consideration given. If the consideration consisted of any note or other obligation,
or if payment was made in installments describe the arrangement and state when
the note or other obligation was discharged in full or the last installment paid. |
TABLE
II –– SECURITIES SOLD DURING THE PAST 3 MONTHS
Furnish the following information as to all securities
of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.
Name and Address of Seller |
Title of Securities Sold |
Date of Sale |
Amount of
Securities Sold |
Gross Proceeds |
Blackboard Ventures Inc., 5650 Yonge Street
Suite 300,
Toronto, ON, M2M 4H5 |
Common Stock |
4/14/2015 |
32,678 |
3,415,213.73 |
INSTRUCTIONS:
See the definition of “person”
in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold
but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons
whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice. |
ATTENTION: The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date. |
May
8, 2015 |
|
/s/ Rossana Di Lieto
|
DATE OF NOTICE |
|
(SIGNATURE) |
|
The notice shall be signed by the person for whose account the securities are to be sold. At least one copy of the notice shall be manually signed. Any copies not manually signed shall bear typed or printed signatures. |
DATE OF PLAN ADOPTION OR GIVING ON INSTRUCTION,
IF RELYING ON RULE 10B5-1 |
ATTENTION:
Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C.
1001)
SEC 1147 (02-08)
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jul 2023 to Jul 2024